DNAs and ctDNAs were subjected to dPCR for KRAS G12D and G13D, and for control PIK3CA H1047R and FBXW7 R505C mutations, to test DNA fragments originating from the same (KRAS) as well as distinct (PIK3CA and FBXW7) genomic loci in two different (LS174T and LoVo) CRC cell lines. This evidence concerns the gene KRAS and colorectal carcinoma.